What's new in April 2008

New for April

• 30 Apr 2008| Warnings about products marketed for treatment of erectile dysfunction

  We have received several warnings from overseas authorities about seven products being marketed as dietary supplements or "herbal Viagra" for the treatment of erectile dysfunction.

• 30 Apr 2008| Press release: Medical devices regulator issues alert over walking frames

  We are urging adults and children to be vigilant if using walking frames manufactured by Trulife Limited, due to concerns over the plastic height adjustment clips that can fail, causing the user to fall.

• 30 Apr 2008| MDA/2008/031 - Walking frames for adults and children manufactured by Trulife Limited

  This Medical Device Alert highlights a problem with the plastic height adjustment clips which can fail, causing the user to fall.

• 29 Apr 2008| MHRA Corporate Plan, Business Plan and summary report of responses to our public consultation on our five-year strategy published

  We have today published our Corporate Plan for 2008-2013 and Business Plan for 2008/2009. We have also published a summary report on the issues raised by consultees in response to our public consultation on challenges and priorities for the next five years.

• 29 Apr 2008| MDA/2008/030 - Surgical blades manufactured by ConMed Linvatec Hall®

  This Medical Device Alert highlights the possibility of holes in the packaging of the above product which may compromise sterility.

• 28 Apr 2008| New Medical Device Technology Forum: Have your say on novel technology issues!

  We are pleased to announce that we are setting up a new Medical Device Technology Forum to look at the impact of novel technologies in the devices area, and are inviting your proposals for topics for discussion.

• 25 Apr 2008| European Commission public consultation: Legal proposal on information to patients

  We have today published the UK government response to the European Commission’s consultation, “Legal proposal on information to patients”.

• 25 Apr 2008| Press release: Doctor prosecuted for advertising and selling an unlicensed medicine - ‘Fat Jab’

  We have successfully prosecuted a man from Nottingham at the City of London Magistrates Court on Wednesday 23 April 2008 for illegally possessing with intention to sell and advertising the unlicensed drug, Lipostabil®, for cosmetic purposes.

• 24 Apr 2008| Press release: Medicines regulator advises healthcare professionals about heparin injection - Clexane

  We have been made aware by Sanofi-Aventis that some batches of Clexane (enoxaparin) on the UK market contain low levels of an impurity called over-sulphated-chondroitin-sulphate (OSCS).

• 24 Apr 2008| Class 4 Drug Alert (Caution in Use): Low molecular weight heparin - Enoxaparin Sodium ("Clexane") pre-filled syringes

  We have recently been informed that some batches of enoxaparin sodium (Clexane) pre-filled syringes with low levels of over-sulphated-chondroitin-sulphate (OSCS) have been distributed in the UK over a period of 4 to 6 weeks.